Unhealthy lobbying: There is reason to fear the influence of Big Pharma

‘The tactics of big pharmaceutical companies often come under the microscope. A report today lays bare the extent of their efforts to lobby Europe’s premier political institutions, both directly and indirectly.

This newspaper has long called for greater transparency when it comes to commercial lobbying of legislators. The Lobbying Act was introduced during the last parliament in response to domestic scandals – though the reforms it brought about were half-hearted, if not counter-productive. The focus of today’s report by campaigners from the Corporate Europe Observatory is Brussels, where the pharmaceutical industry spends a staggering €40m (£29m) a year gaining access to European Commission politicians and officials. In fact, the figure is almost certainly higher because the declaration of EC lobbying remains voluntary.’

Read more: Unhealthy lobbying: There is reason to fear the influence of Big Pharma

The post Unhealthy lobbying: There is reason to fear the influence of Big Pharma appeared first on David Icke.